肥胖严重脓毒症患者基于体重液体复苏策略的比较
该研究回顾性纳入2018年10月至2019年9月在某学术三级医疗中心因严重脓毒症入院并经由脓毒症医嘱套餐下达液体负荷医嘱的肥胖患者72例,比较按理想体重(IBW)30 mL/kg与非IBW 30 mL/kg液体复苏策略的复合结局。主要终点为进展为脓毒性休克,定义为30 mL/kg液体负荷结束后3小时内持续低血压或负荷后6小时内启动血管升压药。IBW组49例(68%)、非IBW组23例(32%),进展为脓毒性休克比例分别为18% vs 26%(p=0.54),无显著差异;ICU住院天数中位数0(IQR 0)vs 0(IQR 0至4)天(p=0.13),医院住院天数中位数6(IQR 3至10)vs 8(IQR 5至12)天(p=0.07),住院死亡率相似。作者认为,在肥胖脓毒症患者中,采用IBW给药策略进行液体复苏未影响进展为脓毒性休克。
要点
- 肥胖严重脓毒症患者按IBW 30 mL/kg与非IBW 30 mL/kg液体复苏,进展为脓毒性休克比例18% vs 26%(p=0.54),无显著差异。
- 复合终点定义为30 mL/kg液体负荷结束后3小时内持续低血压或负荷后6小时内启动血管升压药。
- ICU住院天数中位数IBW组0(IQR 0)天 vs 非IBW组0(IQR 0至4)天(p=0.13),医院住院天数6(IQR 3至10)天 vs 8(IQR 5至12)天(p=0.07)。
- 作者结论认为IBW给药策略未影响肥胖脓毒症患者进展为脓毒性休克。
适用人群与场景
- 肥胖患者,因严重脓毒症入住学术三级医疗中心,且在2018年10月至2019年9月期间经由脓毒症医嘱套餐下达液体负荷医嘱。
诊断标准与关键阈值
- 进展为脓毒性休克的复合定义:30 mL/kg液体负荷结束后3小时内持续低血压,或液体负荷后6小时内启动血管升压药。
处置流程与药物剂量
- 比较两种液体复苏剂量策略:按理想体重(IBW)30 mL/kg vs 按非IBW 30 mL/kg。
研究设计与关键结果
- 回顾性研究,纳入72例肥胖严重脓毒症患者,IBW组49例(68%),非IBW组23例(32%)。
- 主要终点进展为脓毒性休克:IBW组18% vs 非IBW组26%(p=0.54),无显著差异。
- ICU住院天数中位数:IBW组0(IQR 0)天 vs 非IBW组0(IQR 0至4)天(p=0.13)。
- 医院住院天数中位数:IBW组6(IQR 3至10)天 vs 非IBW组8(IQR 5至12)天(p=0.07)。
证据类型、等级与局限
- 证据类型:回顾性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在肥胖脓毒症患者中,采用IBW给药策略进行液体复苏未影响进展为脓毒性休克。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: This study aims to compare the composite outcome of progression to septic shock between 30 mL/kg/ideal body weight (IBW) versus 30 mL/kg/non-IBW fluid resuscitation dosing strategies in obese patients with severe sepsis.
METHODS: We retrospectively evaluated obese patients admitted to an academic tertiary care center for the management of severe sepsis. Patients were included if they had a fluid bolus order placed using the sepsis order set between Oct 2018 and Sept 2019. The primary objective was the composite of progression to septic shock, defined as either persistent hypotension within 3 h after the conclusion of the 30 mL/kg fluid bolus administration or the initiation of vasopressor(s) within 6 h of the bolus administration.
RESULTS: Of 72 included patients, 49 (68%) were resuscitated using an IBW-based and 23 (32%) using a non-IBW-based dosing strategy. There were similar rates of progression to septic shock in the IBW and non-IBW groups (18% vs. 26%; p = 0.54). Median ICU and hospital LOS in the IBW group versus non-IBW group were (0 [IQR 0] vs. 0 [IQR 0 to 4] days; p = 0.13) and (6 [IQR 3 to 10] vs. 8 [IQR 5 to 12] days; p = 0.07), respectively. In-hospital mortality rates were similar between the groups.
CONCLUSIONS: Our study results suggest that in obese septic patients, fluid administration using an IBW-dosing strategy did not affect the progression to septic shock.
参考来源
- Kaseer HS, Patel R, Tucker C, et al. Comparison of fluid resuscitation weight-based dosing strategies in obese patients with severe sepsis. Am J Emerg Med. 2021. PMID: 34171722. doi:10.1016/j.ajem.2021.06.036
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。